Driving efficiency across upstream bioprocess workflow
Drug Target Review
MARCH 15, 2024
He has a post-doctorate in virology, viral pathogenesis, viral vector development, and vaccines evaluation from Harvard Medical School, and a PhD in virology/molecular biology. Anis also serves on the scientific and editorial advisory board of Genetic Engineering News at Mary Ann Liebert, Inc.
Let's personalize your content